相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival
Niklas Thon et al.
CANCER (2012)
Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas
Sohei Yamamoto et al.
MODERN PATHOLOGY (2012)
Targeting MET in cancer: rationale and progress
Ermanno Gherardi et al.
NATURE REVIEWS CANCER (2012)
Genetic profile of astrocytic and oligodendroglial gliomas
Hiroko Ohgaki et al.
BRAIN TUMOR PATHOLOGY (2011)
c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme
Wei Liu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
Francesco Graziano et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gain of chromosome 7 by chromogenic in situ hybridization (CISH) in chordomas is correlated to c-MET expression
Beatriz A. Walter et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
Neelesh Sharma et al.
Therapeutic Advances in Medical Oncology (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Molecular Classification of Low-Grade Diffuse Gliomas
Young Ho Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Update on molecular findings, management and outcome in low-grade gliomas
T. David Bourne et al.
NATURE REVIEWS NEUROLOGY (2010)
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
C. Houillier et al.
NEUROLOGY (2010)
Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
Soundararajan Krishnaswamy et al.
CLINICAL CANCER RESEARCH (2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Sumihito Nobusawa et al.
CLINICAL CANCER RESEARCH (2009)
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients
Federico Cappuzzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts
Bachchu Lal et al.
MOLECULAR CANCER THERAPEUTICS (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Expression and Mutational Analysis of MET in Human Solid Cancers
Patrick C. Ma et al.
GENES CHROMOSOMES & CANCER (2008)
Genomic changes in progression of low-grade gliomas
Ahmed Idbaih et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas
Ali Arslantas et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
A novel one-armed anti-c-met antibody inhibits glioblastoma growth in vivo
Tobias Martens et al.
CLINICAL CANCER RESEARCH (2006)
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma
R Jagadeeswaran et al.
CANCER RESEARCH (2006)
A retrospective analysis of the management of parapneumonic empyemas in a county teaching facility from 1992-2004
G Cheng et al.
CHEST (2005)
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
R Abounader et al.
NEURO-ONCOLOGY (2005)
Analysis by comparative genomic hybridization of gastric cancer with peritoneal dissemination and/or positive peritoneal cytology
K Morohara et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Comparative genomic hybridization analysis of astrocytomas - Prognostic and diagnostic implications
RN Wiltshire et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas
Y Okamoto et al.
ACTA NEUROPATHOLOGICA (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome
H Schmidt et al.
GENES CHROMOSOMES & CANCER (2002)
c-Met expression in gastric cancer with liver metastasis
H Amemiya et al.
ONCOLOGY (2002)
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay
JM Nigro et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
